Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases
Authors:
- Theodoros KiropoulosTKTheodoros Kiropoulos
- Konstantinos GourgoulianisKGKonstantinos Gourgoulianis
- Gerasimos FilippatosGFGerasimos Filippatos
- 31 August 2008
- journal article
- Published by Elsevier in Heart & Lung
- Vol. 37 (4) , 275-285
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Natriuretic Peptides and Mortality After StrokeStroke, 2005
- The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) studyThe American Journal of Cardiology, 2005
- Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT)JACC, 2004
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplastyClinical Cardiology, 2000
- Brain Natriuretic Peptide and Cerebral Vasospasm in Subarachnoid HemorrhageStroke, 2000
- Interleukin-1β Regulates the Human Brain Natriuretic Peptide Promoter via Ca2+-Dependent Protein Kinase PathwaysHypertension, 2000
- Interleukin-1β Regulation of the Human Brain Natriuretic Peptide Promoter Involves Ras-, Rac-, and p38 Kinase–Dependent Pathways in Cardiac MyocytesHypertension, 1999
- Natriuretic Peptides Inhibit DNA Synthesis in Cardiac FibroblastsHypertension, 1995
- Effects of heart failure on baroreflex control of sympathetic neural activityThe American Journal of Cardiology, 1992